4.5 Article

The clinical spectrum of IgM-Related amyloidosis - A French mnationwide retrospective study of 72 patients

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis

Arnaud Jaccard et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Hematology

AL amyloidosis associated with B-cell lymphoproliferative disorders: Frequency and treatment outcomes

V. Sanchorawala et al.

AMERICAN JOURNAL OF HEMATOLOGY (2006)

Article Oncology

Autologous stem cell transplantation and IgM amyloidosis

Maria Valente et al.

LEUKEMIA & LYMPHOMA (2006)

Review Oncology

Prognostic factors in symptomatic Waldenstrom's macroglobulinemia

G Merlini et al.

SEMINARS IN ONCOLOGY (2003)

Review Oncology

Amyloidosis with IgM monoclonal gammopathies

MA Gertz et al.

SEMINARS IN ONCOLOGY (2003)

Article Medicine, General & Internal

Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

HJ Lachmann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Medicine, General & Internal

A long-term study of prognosis in monoclonal gammopathy of undetermined significance

RA Kyle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Urology & Nephrology

Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family

S Valleix et al.

KIDNEY INTERNATIONAL (2002)

Article Hematology

Waldenstrom macroglobulinaemia:: presenting features and outcome in a series with 217 cases

R García-Sanz et al.

BRITISH JOURNAL OF HAEMATOLOGY (2001)

Article Hematology

Waldenstrom's macroglobulinemia associated with AA amyloidosis

J Gardyn et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)